Scientist Home Future Health Ltd financial statements
Income statement, balance sheet and cash flow statement for the last 1 fiscal years, taken from the XBRL data Scientist Home Future Health Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2025
Revenue
0.2
Cost of revenue
0.12
Gross profit
0.08
Selling, general and administrative
0.31
Operating expenses
-0.31
Operating income
-0.23
Pre-tax income
-0.23
Income tax
0
Net income
-0.23
EBITDA
-0.23
EPS, diluted
-0.01
Shares, diluted (weighted)
23.6
Balance sheet
FY2025
Cash and equivalents
0.07
Inventory
0.03
Other current assets
0.09
Total current assets
0.19
Property, plant and equipment
0.07
Lease right-of-use assets
0.38
Total assets
0.64
Accounts payable
0.04
Accrued liabilities
0.02
Total current liabilities
0.21
Lease liabilities
0.32
Total liabilities
0.53
Paid-in capital
0.36
Retained earnings
-0.25
Other comprehensive income
-0
Shareholders' equity
0.11
Total equity
0.11
Total liabilities and equity
0.64
Shares outstanding
23.7
Cash flow statement
FY2025
Net income
-0.23
Depreciation and amortization
0
Deferred income tax
0
Change in inventory
-0.03
Change in payables
0.03
Cash from operations
-0.25
Capital expenditures
-0.07
Cash from investing
-0.07
Stock issued
0.35
Cash from financing
0.38
Exchange rate effect
-0
Free cash flow
-0.32
Interest paid
0
Income taxes paid
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.70 on October 22, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
34.3%
Gross profit / revenue.
Operating margin
-100.3%
Operating income / revenue.
Pre-tax margin
-100.3%
Pre-tax income / revenue.
Net margin
-100.3%
Net income / revenue.
Operating cash flow margin
-80.8%
Cash from operations / revenue.
Return on assets (ROA)
-75.6%
Net income / average total assets.
SG&A / revenue
134.6%
Selling, general and administrative expense / revenue.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.37x
Current assets / current liabilities.
Quick ratio
0.03x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.03x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.02
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
101x
Market cap / revenue.
EV/Sales
101x
Enterprise value / revenue.
Earnings yield
-1.0%
Net income / market cap (the inverse of P/E).
What was Scientist Home Future Health Ltd's revenue in fiscal 2025?
Scientist Home Future Health Ltd reported revenue of $204.1K for fiscal 2025.
Was Scientist Home Future Health Ltd profitable in fiscal 2025?
No. It reported a net loss of $231.7K.
How much free cash flow did Scientist Home Future Health Ltd generate in fiscal 2025?
Cash from operations of $248.3K minus capital expenditures of $74.8K left free cash flow of -$323.1K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.